Collaborate on Investigator-Initiated Research.
We are actively partnering with pharmaceutical companies on response monitoring, host response diagnostics, and transcriptomic biomarker discovery. If your pipeline would benefit from real-time molecular readouts — let's talk.
48
Molecular Targets
<15 min
Sample to Results
CLIA
Certified Lab
1.9 lbs
Field Deployable
Backed by Leading Research & Defense Organizations
A Two-Phase Approach to Precision Partnerships
We don't just provide instruments — we co-develop the molecular evidence layer for your therapeutic programs.
Discovery & Validation
Biomeme provides portable molecular testing infrastructure for investigator-initiated trials. Our platform enables gene expression monitoring at the point of need — not just the central lab — giving your research team real-time transcriptomic data across up to 48 targets simultaneously.
- Field-deployable molecular testing
- 48-target multiplexed gene expression panels
- Longitudinal biomarker discovery protocols
- CLIA-certified lab processing via One Health Labs
Companion Diagnostics
Validated biomarker panels from Phase 1 transition from research tools to regulatory-grade companion diagnostics deployed on Biomeme hardware. The same platform your investigators used in discovery becomes the clinical-grade instrument in your commercial workflow.
- Research-to-clinical pathway on a single platform
- Custom panel development & manufacturing
- Point-of-care deployment for clinical trials
- Regulatory strategy support
The same platform your investigators use in discovery becomes the clinical-grade instrument in your commercial workflow.
From bench to bedside — on a single platform.
Start a Conversation
Tell us about your therapeutic program and we'll connect you with the right team.
Active Partnership Areas
-
GLP-1 & Metabolic
Response monitoring, responder stratification
-
Host Response & Sepsis
Immune profiling, antimicrobial stewardship
-
Infectious Disease
Pathogen detection, pandemic preparedness
-
Custom Panels
Bespoke assay development for your targets
Why Biomeme?
- → 48-target multiplexed gene expression in <15 minutes
- → Portable platform deployable at any clinical site
- → CLIA-certified lab (One Health Labs)
- → Isothermal DTECT® chemistry
- → Single platform from discovery through commercialization